MétaCan
Menu
Back to cohort
Record W2166790944 · doi:10.2174/157016110793563825

Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia

2010· review· en· W2166790944 on OpenAlexaboutno aff
Matilda Florentin, A.D. Tselepis, Moses Elisaf, Christos V. Rizos, Dimitri P. Mikhailidis, Evangelos Liberopoulos

Bibliographic record

VenueCurrent Vascular Pharmacology · 2010
Typereview
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsnot available
Fundersnot available
KeywordsEzetimibeOrlistatMedicineRimonabantInternal medicineEndocrinologyStatinOverweightNiacinMetabolic syndromeSibutramineLipid profileObesityLipoproteinPharmacologyWeight lossCholesterolAntagonistReceptor

Abstract

fetched live from OpenAlex

Small, dense low density lipoprotein (sdLDL) particles are considered an emerging cardiovascular risk factor. Obese patients with mixed dyslipidaemia frequently have elevated sdLDL cholesterol (sdLDL-C) levels. Therefore, agents that favourably modulate the LDL phenotype may be of clinical value in these patients. We review the efficacy of anti-obesity and lipid lowering drugs other than statins on LDL subfractions in patients with mixed dyslipidaemia primarily focusing on those who are overweight/obese. The literature search was based on PubMed listings up to 26 November 2009. In most studies ezetimibe decreases the large and medium LDL subclasses and, to a lesser extent, the sdLDL particles, while it does not substantially influence LDL size. Fibrates and niacin reduce sdLDL particles and shift LDL size towards large, buoyant LDL particles. More studies are needed to elucidate the effects of fish oils and resins on LDL phenotype. Orlistat and rimonabant have been associated with reductions in sdLDL-C levels along with an increase in LDL particle size. We did not find any literature describing the effect of sibutramine on sdLDL profile. Treatment with fibrates and niacin seems to be beneficial in patients with mixed dyslipidaemia. The addition of orlistat may further improve LDL phenotype in overweight/obese patients. Keywords: Mixed dyslipidaemia, ezetimibe, fibrates, nicotinic acid, obesity, orlistat, rimonabant, small, dense LDL, Non-Statin Lipid, Anti-Obesity Drugs, LDL Sub-fractions, sdLDL, sibutramine, Quebec Cardiovascular Study, ischemic heart disease, proteoglycan, LDL receptors, thromboxane A2, thrombogenicity, cardiovascular risk, high density lipoprotein cholesterol, metabolic syndrome, National Cholesterol Education Program Adult Treat-ment Panel III, cardio-vascular disease, fenofi-brate, bezafibrate, gemfibrozil, ciprofibrate, clofibrate, niacin, resins, sequestrants, coleseve-lam, omega-3, fatty acids, fish oil, high density, low density lipoprotein cholesterol, triglycerides, hyperlipidaemia, Lipoprint LDL System, hyper-cholesterolaemia, hyperlipoproteinaemia, LDL apheresisc, fenofibrate, Intraabdominal Adiposity

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.002
Threshold uncertainty score0.008

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.335
Teacher spread0.323 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations30
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueCurrent Vascular PharmacologySame topicLipoproteins and Cardiovascular HealthFrench-language works237,207